Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED) : an international, randomised, open-label, blinded-endpoint, phase 3 trial
Craig S. Anderson, Yining Huang, Richard I. Lindley, Xiaoying Chen, Hisatomi Arima, Guofang Chen, Qiang Li, Laurent Billot, Candice Delcourt, Philip M. Bath, Joseph P. Broderick, Andrew M. Demchuk, Geoffrey A. Donnan, Alice C. Durham, Pablo M. Lavados, Tsong-Hai Lee, Christopher Levi, Sheila O. Martins, Veronica V. Olavarria, Jeyaraj D. PandianMark W. Parsons, Octavio M. Pontes-Neto, Stefano Ricci, Shoichiro Sato, Vijay K. Sharma, Federico Silva, Lili Song, Nguyen H. Thang, Joanna M. Wardlaw, Ji-Guang Wang, Xia Wang, Mark Woodward, John Chalmers, Thompson G. Robinson, M. Krause, M. Priglinger, S. Day, S. Jala, C. Carcel, A. Malavera, E. Ray E., T. Wijeratne, S. Celestino, L. Y. Law, G. Ng. G., K. Nagao, G. Weiss, N. Titton, C. Batista, D. Zan, et al.
Research output: Contribution to journal › Article › peer-review
203Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED) : an international, randomised, open-label, blinded-endpoint, phase 3 trial'. Together they form a unique fingerprint.